Malignancy-associated pulmonary veno-occlusive disease: Report of a case following autologous bone marrow transplantation and review

Bone Marrow Transplantation

Volumn 18, Issue 4, 1996, Pages 755-760

  Salzman, D ^a   Adkins, D R ^b   Craig, F ^c   Freytes, C ^d   LeMaistre, C F ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c Mays Cancer Center at UT Health San Antonio   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e South Texas Genetics Center   (United States)

Author keywords

Bone marrow transplantation; Malignancy; Pulmonary VOD

Indexed keywords

ANTIINFECTIVE AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; STEROID; VINCRISTINE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CASE REPORT; HUMAN; HUMAN TISSUE; HYPOTENSION; LUNG FIBROSIS; LUNG VEIN OBSTRUCTION; LYMPHOMA; MALE; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VEIN; VENULE; VOMITING;

ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; DACARBAZINE; HUMANS; HYPERTENSION, PULMONARY; LYMPHOMA, SMALL LYMPHOCYTIC; MALE; PULMONARY VENO-OCCLUSIVE DISEASE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029807442     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Wagenvoort CA, Wagenvoort N. The pathology of pulmonary veno-occlusive disease. Virch Arch A Path Histol 1974; 364; 69-79.
2. Wagenvoort CA. Pulmonary veno-occlusive disease: entity or syndrome? Chest 1976; 69: 82-86.
3. Ruchelli ED, Nojadera G, Rutstein RM, Rudy B. Pulmonary veno-occlusive disease: another vascular disorder associated with human immunodeficiency virus infection? Arch Pathol Lab Med 1994; 118: 664-666.
4. Liu L, Sackler JP. A case of pulmonary veno-occlusive disease: etiological and therapeutic appraisal. Angiology 1972; 23: 299-304.
5. Townend JN, Roberts DH, Jones EL, Davies MK. Fatal pulmonary veno-occlusive disease after use of oral contraceptives. Am Heart J 1992; 124: 1643-1644.
6. Cagle P, Langston C. Pulmonary veno-occlusive disease as a cause of sudden infant death. Arch Pathol Lab Med 1984; 108: 338-340.
7. Canny GJ, Arbus GS, Wilson GJ, Newth CJL. Fatal pulmonary hypertension following renal transplantation. Br J Dis Chest 1985; 79: 191-194.
8. Sanderson JE, Spiro SG, Hendry AT, Turner-Warwick M. A case of pulmonary veno-occlusive disease responding to treatment with azathioprine. Thorax 1977; 32: 140-148.
9. Kishida Y, Kanai Y, Kuramochi S, Hosoda Y. Pulmonary veno-occlusive disease in a patient with systemic lupus erythematosus. J Rheumatol 1993; 20: 2161-2162.
10. Corrin B, Spencer H, Turner-Warwick M et al. Pulmonary veno-occlusion - an immune complex disease? Virchows Arch 1974; 364: 81-91.
11. Morassut PA, Walley VM, Smith CD. Pulmonary veno-occlusive disease and the CREST variant of scleroderma. Can J Card 1992; 8: 1055-1058.
12. Voordes CG, Kuipers JRG, Elema JD. Familial pulmonary veno-occlusive disease: a case report. Thorax 1977; 32: 763-766.
13. Hasleton PS, Ironside JW, Whittaker JS et al. Pulmonary veno-occlusive disease: a report of four cases. Histopathology 1986; 10: 933-944.
14. Swift GL, Gibbs A, Campbell IA et al. Case report: pulmonary veno-occlusive disease and Hodgkin's lymphoma. Eur Respir J 1993; 6: 596-598.
15. Capewell SJ, Wright AJ, Ellis DA. Pulmonary veno-occlusive disease in association with Hodgkin's disease. Thorax 1984; 39: 554-555.
16. Lombard CM, Churg A, Winokur S. Pulmonary veno-occlusive disease following therapy for malignant neoplasms. Chest 1987; 92: 871-876.
17. Knight BK, Rose AG. Pulmonary veno-occlusive disease after chemotherapy. Thorax 1985; 40: 874-875.
18. Joselson R, Warnock M. Pulmonary veno-occlusive disease after chemotherapy. Hum Pathol 1983; 14: 88-91.
19. Kramer MR, Estenne M, Berkman N et al. Radiation-induced pulmonary veno-occlusive disease. Chest 1993; 104: 1282-1284.
20. Rose AG. Pulmonary veno-occlusive disease due to bleomycin therapy for lymphoma. SA Med J 1983; 64: 636-638.
21. Troussard X, Bernaudin JF, Cordonnier C et al. Pulmonary veno-occlusive disease after bone marrow transplantation. Thorax 1984; 39: 956-957.
22. Wingard JR, Mellits ED, Jones RJ et al. Association of hepatic veno-occlusive disease with interstitial pneumonitis in bone marrow transplant recipients. Bone Marrow Transplant 1989; 4: 685-689.
23. Hackman RC, Madtes DK, Petersen FB, Clark JG. Pulmonary veno-occlusive disease following bone marrow transplantation. Transplantation 1989; 47: 989-992.
24. Adkins D, Salzman D, Boldt D et al. Phase I trial of dacarbazine with cyclosphosphamide, etoposide and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma. J Clin Oncol 1994; 12: 1890-1901.
25. Scully RE, Mark EJ, McNeely BU. Case records of the Massachusetts General Hospital. New Engl J Med 1988; 308: 823-834.
26. Wagenvoort CA, Wagenvoort N, Takahashi T. Pulmonary veno-occlusive disease: involvement of pulmonary arteries and review of the literature. Hum Pathol 1985; 16: 1033-1041.
27. Rich S, Pietra GG, Kieras K et al. Primary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. Ann Int Med 1986; 105: 499-502.
28. Stovin PGI, Mitchinson MJ. Pulmonary hypertension due to obstruction of the intrapulmonary veins. Thorax 1965; 20: 106-113.
29. Heath D, Segel N, Bishop J. Pulmonary veno-occlusive disease. Circulation 1966; 34: 242-247.
30. Tingelstad JB, Aterman K, Lambert EC. Pulmonary venous obstruction: report of a case mimicking primary pulmonary arterial hypertension with a review of the literature. Am J Dis Child 1969; 117: 219-227.
31. Clinicopathological conference: a case of veno-occlusive disease. Br Med J 1968; 3: 818-822.
32. McDonald GB, Sharma P, Matthew DE et al. Veno-occlusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116-122.
33. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease-liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197-214.
34. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Int Med 1993; 118: 255-267.
35. Bearman SI. Review: the syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
36. Erichsen C, Jonsson PE. Veno-occlusive liver disease after dacarbazine therapy (DTIC) for melanoma. J Surg Oncol 1984; 27: 268-270.
37. Adkins D, Irvin R, Kuhn J et al. A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors. Invest New Drugs 1993; 11: 169-179.
38. Salzman GA, Rosa UW. Prolonged survival in pulmonary veno-occlusive disease treated with nifedipine. Chest 1989; 95: 1154-1156.
39. Wong J, Loyd JE, Merrill WH, Frist WH. Single lung transplantation: replacement therapy for end-stage lung disease. South Med J 1992; 85: 887-892.
40. Waldhorn RE, Tsou E, Smith FP, Kerwin DM. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma. Med Ped Oncol 1984; 12: 394-396.